Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222

ABSTRACT: Objective: To determine whether severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels after the first dose of vaccine can predict the final antibody response, and whether this is dependent on the vaccine type.Methods: Sixty-nine recipients of BNT162b2 (Pfizer/BioNTec...

Full description

Bibliographic Details
Main Authors: Thomas Perkmann, Nicole Perkmann-Nagele, Patrick Mucher, Astrid Radakovics, Manuela Repl, Thomas Koller, Galateja Jordakieva, Oswald F. Wagner, Christoph J. Binder, Helmuth Haslacher
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:International Journal of Infectious Diseases
Subjects:
Age
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221006202